Evidence map›Paper›PMID 27495752›Full record

ArticleTransplantation2017

Increased Extravascular Lung Water and Plasma Biomarkers of Acute Lung Injury Precede Oxygenation Impairment in Primary Graft Dysfunction After Lung Transplantation.

Julien Pottecher, Anne-Claude Roche, Tristan Dégot, Olivier Helms, Jean-Gustave Hentz, Jean-Paul Schmitt, Pierre-Emmanuel Falcoz, Nicola Santelmo, François Levy, Olivier Collange and 11 more

Abstract read
PubMed Publisher
In one paragraph

Article in Transplantation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Feasibility and accuracy of DireCt Lung Ultrasound Evaluation technique to monitor extravascular lung water in porcine lungs.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2024
    Article
  4. Article
  5. Article
  6. Temporal correlation between postreperfusion complement deposition and severe primary graft dysfunction in lung allografts.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2024
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Pulmonary Vascular Permeability Indices: Fine Prints of Lung Protection?Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2020
    Article
  12. The ATP-gated P2XScientific reports · 2019
    Article
  13. Early Graft Dysfunction after Lung Transplantation.Current pulmonology reports · 2018
    Article
  14. Review
  15. Article
  16. Protein biomarkers associated with primary graft dysfunction following lung transplantation.American journal of physiology. Lung cellular and molecular physiology · 2017
    Review
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 1 institution in 2 countries.

Julien Pottecher1 Hôpitaux Universitaires de Strasbourg, Pôle d'Anesthésie-Réanimation SAMU-SMUR, Service d'Anesthésie-Réanimaton Chirurgicale, Hôpital de Hautepierre, Université de Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Institut de Physiologie, Strasbourg, France. 2 Hôpitaux Universitaires de Strasbourg, Pôle d'Anesthésie-Réanimation SAMU-SMUR, Service d'Anesthésie-Réanimations Chirurgicales, Nouvel Hôpital Civil, Strasbourg, France. 3 Hôpitaux Universitaires de Strasbourg, Pôle de Pathologie Thoracique, Service de Pneumologie, Nouvel Hôpital Civil, Strasbourg, France. 4 Hôpitaux Universitaires de Strasbourg, Pôle de Pathologie Thoracique, Service de Chirurgie Thoracique, Nouvel Hôpital Civil, Strasbourg, France. 5 Hôpitaux Universitaires de Strasbourg, Pôle de Biologie, Laboratoire Central d'Immunologie, Nouvel Hôpital Civil, Strasbourg, France. 6 Laboratoire d'ImmunoRhumatologie Moléculaire, LabEx Transplantex, Centre de Recherche d'Immunologie et d'Hématologie, Faculté de Médecine, Fédération de Médecine Translationnelle de Strasbourg, Université de Strasbourg, France. 7 Hôpitaux Universitaires de Strasbourg, Service de Santé Publique, Groupe Méthode en Recherche Clinique, Strasbourg, France. 8 Université de Strasbourg, Faculté de Médecine, Laboratoire de Biostatistique et Informatique Médicale, EA3430 Progression Tumorale et Microenvironnement. Approches translationnelles et Epidemiologie', LabEx IRMIA, Strasbourg, France. 9 Hôpitaux Universitaires de Strasbourg, Pôle de Pathologie Thoracique, Service de Physiologie et d'Explorations Fonctionnelles, Nouvel Hôpital Civil, Université de Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Institut de Physiologie, Strasbourg, France. 10 Institut National de la Santé et de la Recherche Médicale, U1019, Pulmonary Immunity team and Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France.
Anne-Claude Roche
Tristan Dégot
Olivier Helms
Jean-Gustave Hentz
Jean-Paul Schmitt
Pierre-Emmanuel Falcoz
Nicola Santelmo
François Levy
Olivier Collange
Béatrice Uring-Lambert
Siamak Bahram
Mickaël Schaeffer
Nicolas Meyer
Bernard Geny
Philippe Lassalle
Pierre Diemunsch
Gilbert Massard
Romain Kessler
Annick Steib
Groupe de Transplantation Pulmonaire des Hôpitaux Universitaires de Strasbourg
Hôpitaux Universitaires de Strasbourg · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAfter lung transplantation (LT), early prediction of grade 3 pulmonary graft dysfunction (PGD) remains a research gap for clinicians. We hypothesized that it could be improved using extravascular lung water (EVLWi) and plasma biomarkers of acute lung injury.

methodsAfter institutional review board approval and informed consent, consecutive LT recipients were included. Transpulmonary thermodilution-based EVLWi, plasma concentrations of epithelial (soluble receptor for advanced glycation endproducts [sRAGE]) and endothelial biomarkers (soluble intercellular adhesion molecule-1 and endocan [full-length and cleaved p14 fragment]) were obtained before and after LT (0 [H0], 6, 12, 24, 48 and 72 hours after pulmonary artery unclamping). Grade 3 PGD was defined according to the International Society for Lung and Heart Transplantation definition, combining arterial oxygen partial pressure (PaO2)/inspired fraction of oxygen (FiO2) ratio and chest X-rays. Association of clinical risk factors, EVLWi and biomarkers with grade 3 PGD was analyzed under the Bayesian paradigm, using logistic model and areas under the receiver operating characteristic curves (AUCs).

resultsIn 47 LT recipients, 10 developed grade 3 PGD, which was obvious at H6 in 8 cases. Clinical risk factors, soluble intercellular adhesion molecule-1 and endocan (both forms) were not associated with grade 3 PGD. Significant predictors of grade 3 PGD included (1) EVLWi (optimal cutoff, 13.7 mL/kg; AUC, 0.74; 95% confidence interval [CI], 0.48-0.99), (2) PaO2/FiO2 ratio (optimal cutoff, 236; AUC, 0.68; 95% CI, 0.52-0.84), and (3) sRAGE (optimal cutoff, 11 760 pg/mL; AUC, 0.66; 95% CI, 0.41-0.91) measured at H0.

conclusionsImmediate postreperfusion increases in EVLWi and sRAGE along with impaired PaO2/FiO2 ratios were early predictors of grade 3 PGD at or beyond 6 hours and may trigger early therapeutic interventions.

Indexed as

Acute Lung InjuryAdultArea Under CurveBayes TheoremBiomarkersDisease ProgressionEarly DiagnosisExtravascular Lung WaterFemaleHumansIntercellular Adhesion Molecule-1LungLung TransplantationMaleMiddle AgedNeoplasm ProteinsAGER protein, humanBiomarkersESM1 protein, humanICAM1 protein, humanIntercellular Adhesion Molecule-1Neoplasm ProteinsOxygenProteoglycansReceptor for Advanced Glycation End Products

Identifiers

PMID27495752
OpenAlexW2508675489

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.